China plans to require type testing and mandatory clinical trials for higher-risk devices
This article was originally published in Clinica
Executive Summary
China is planning to impose new requirements on foreign medical device companies. The proposed law, which includes mandatory clinical trials for long-term implantables and type testing for medium- and high-risk devices, is expected to be promulgated at the end of this year by the Chinese State Council.